About this trial
This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early PreVEntion in the GREAT LakEs Region) Center (IRB 100221MP2A), the purpose of which is to reduce cardiometabolic health disparities in two cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center involves four separate but related projects that aim to mitigate health disparities in risk factor control for three chronic conditions, hypertension (HTN, Project 1), heart failure (HF, Projects 2 and 4) and coronary heart disease (CHD, Project 3). The first three projects will involve the use of Community Health Workers (CHWs) to deliver an evidence-based practice intervention program called PAL2. Projects 1-3 also utilize the PAL2 Implementation Intervention (PAL2-II), which is a set of structured training and evaluation strategies designed to optimize CHW competence and adherence (i.e., fidelity) to the PAL2 intervention program. The present study is Project 2 of the ACHIEVE GREATER Center.
Eligibility criteria
Qualifiers
Detroit-area resident (defined as those who attended a Detroit-area community event)
≥18 years of age
Disqualifiers
Previous diagnosis of HF
Uncontrolled diabetes (HbA1C ≥8.0% from SOC screening labs)
Chronic use of insulin or >1 anti-diabetic medication
Self-reported pregnancy (or planning to become pregnant in the next year)
Trial design
Treatments tested in this trial
- PAL2
- PHARM-PAL2
Treatment groups
Sponsors and collaborators
Henry Ford Health System
Lead sponsor
Wayne State University
Collaborator